THE EFFECT OF N-ALKYL MODIFICATION ON THE ANTIMALARIAL ACTIVITY OF 3-HYDROXYPYRIDIN-4-ONE ORAL IRON CHELATORS

被引：0
|
作者：
HERSHKO, C
THEANACHO, EN
SPIRA, DT
PETER, HH
DOBBIN, P
HIDER, RC
机构：
[1] HEBREW UNIV JERUSALEM, HADASSAH MED SCH, KUVIN CTR STUDY TROP & INFECT DIS, IL-91010 JERUSALEM, ISRAEL
[2] UNIV LONDON KINGS COLL, CHELSEA DEPT PHARM, LONDON WC2R 2LS, ENGLAND
[3] CIBA GEIGY CORP, BIOTECHNOL RES LABS, SUMMIT, NJ 07901 USA
来源：
BLOOD | 1991年 / 77卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：637 / 643
页数：7
相关论文
共 50 条
  • [31] Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity
    Yokel, RA
    Meurer, KA
    Hong, CB
    Dickey, KM
    Skinner, TL
    Fredenburg, AM
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 182 - 190
  • [32] Comparison of Inhibitory Activities of meta and para Substituted N-aryl 3-Hydroxypyridin-4-one Mannosides Towards Type 1 Fimbriated E. coli
    Perokovic, Vesna Petrovic
    Ribic, Rosana
    Car, Zeljka
    Tomic, Srdanka
    CROATICA CHEMICA ACTA, 2016, 89 (02) : 237 - 242
  • [33] Activity of 17β-(N-alkyl/arylformamido) and 17β-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors in the hamster flank organ and ear
    Chen, CL
    Li, X
    Singh, SM
    Labrie, F
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (02) : 273 - 278
  • [34] Hydrolytic and metabolic characteristics of the esters of 1-(3′-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelators
    Liu, DY
    Liu, ZD
    Lu, SL
    Hider, RC
    PHARMACOLOGY & TOXICOLOGY, 2000, 86 (05): : 228 - 233
  • [35] Design, synthesis, in silico ADME, DFT, molecular dynamics simulation, anti-tyrosinase, and antioxidant activity of some of the 3-hydroxypyridin-4-one hybrids in combination with acylhydrazone derivatives
    Fazel, Razieh
    Hassani, Bahareh
    Zare, Fateme
    Darzi, Habibollah Jokar
    Khoshneviszadeh, Mehdi
    Poustforoosh, Alireza
    Behrouz, Marzieh
    Sabet, Razieh
    Sadeghpour, Hossein
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (18): : 9518 - 9528
  • [36] Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators
    Liu, ZD
    Kayyali, R
    Hider, RC
    Porter, JB
    Theobald, AE
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 631 - 639
  • [37] SYNTHETIC METHODS AND INVITRO IRON-BINDING STUDIES OF THE NOVEL 1-ALKYL-2-ETHYL-3-HYDROXYPYRID-4-ONE IRON CHELATORS
    KONTOGHIORGHES, GJ
    SHEPPARD, L
    BARR, J
    INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1988, 152 (03): : 195 - 199
  • [38] Antimicrobial activity of some N-alkyl and N-nitrobenzyl substituted halides of (E)-4′-hydroxy-3′-methoxystilbazoles-4
    Prukala, W
    Kedzia, B
    FARMACO, 1999, 54 (09): : 584 - 587
  • [39] DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
    Greenshields, Anna L.
    Coombs, Melanie R. Power
    Fernando, Wasundara
    Holbein, Bruce E.
    Hoskin, David W.
    BIOMETALS, 2019, 32 (06) : 909 - 921
  • [40] DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
    Anna L. Greenshields
    Melanie R. Power Coombs
    Wasundara Fernando
    Bruce E. Holbein
    David W. Hoskin
    BioMetals, 2019, 32 : 909 - 921
12345